Envista Holdings Corporation (NVST) - What Are Researchers Saying About This Stock?

Key Points

• Analysts rate Envista a “Hold” overall: 11 of 17 analysts recommend holding and six recommend buying, with an average 12-month price target of $28.86.
• Envista beat quarterly estimates, reporting EPS of $0.40 versus $0.36 expected and revenue of $691.5 million versus $688.74 million; revenue rose 3.2% year over year.
• SVP Mischa Reis sold 8,000 shares for $220,000 under a pre-arranged Rule 10b5-1 plan, reducing his position by 22.65%; insiders collectively own 0.99% of the company.

Shares of Envista Holdings Corporation (NYSE:NVST - Get Free Report) have been given a consensus rating of "Hold" by the seventeen analysts that are covering the company, MarketBeat reports. Eleven equities research analysts have rated the stock with a hold recommendation and six have issued a buy recommendation on the company. The average 1 year target price among brokers that have covered the stock in the last year is $28.86.

A number of research analysts have issued reports on the company. Weiss Ratings upgraded Envista from a "hold (c-)" rating to a "hold (c)" rating in a research report on Thursday, August 6th. Mizuho set a $29.00 price target on Envista in a report on Thursday, August 6th. Deutsche Bank Aktiengesellschaft set a $32.00 price objective on shares of Envista in a research note on Thursday, September 3rd. BMO Capital Markets reduced their price objective on shares of Envista from $29.00 to $26.00 and set a "market perform" rating for the company in a report on Monday, September 28th. Finally, Wall Street Zen downgraded shares of Envista from a "strong-buy" rating to a "buy" rating in a report on Saturday, September 5th.

Insider Buying and Selling

In other Envista news, SVP Mischa Reis sold 8,000 shares of the business's stock in a transaction dated Thursday, August 20th. The shares were sold at an average price of $27.50, for a total transaction of $220,000.00. Following the sale, the senior vice president directly owned 27,321 shares in the company, valued at approximately $751,327.50. The trade was a 22.65% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 0.99% of the company's stock.

Institutional Trading of Envista

Institutional investors have recently made changes to their positions in the stock. Corient Private Wealth LP boosted its position in shares of Envista by 35.8% during the 2nd quarter. Corient Private Wealth LP now owns 703,864 shares of the company's stock valued at $18,547,000 after purchasing an additional 185,687 shares in the last quarter. GSA Capital Partners LLP bought a new stake in shares of Envista in the 2nd quarter worth approximately $2,039,000. Legal & General Group Plc bought a new position in shares of Envista in the second quarter valued at $5,987,000. WINTON GROUP Ltd lifted its holdings in shares of Envista by 247.9% during the second quarter. WINTON GROUP Ltd now owns 192,055 shares of the company's stock valued at $5,061,000 after purchasing an additional 136,855 shares during the last quarter. Finally, Squarepoint Ops LLC purchased a new stake in Envista during the second quarter valued at about $1,464,000.

Envista Stock Performance

Shares of NYSE NVST opened at $27.21 on Thursday. Envista has a 12-month low of $18.77 and a 12-month high of $30.42. The company has a market cap of $4.37 billion, a PE ratio of 46.91, a P/E/G ratio of 1.26 and a beta of 0.94. The stock has a 50 day simple moving average of $24.49 and a 200-day simple moving average of $25.74. The company has a current ratio of 2.43, a quick ratio of 2.07 and a debt-to-equity ratio of 0.47.

Envista (NYSE:NVST - Get Free Report) last posted its earnings results on Wednesday, November 4th. The company reported $0.40 EPS for the quarter, beating the consensus estimate of $0.36 by $0.04. Envista had a return on equity of 7.88% and a net margin of 3.33%. The firm had revenue of $691.50 million for the quarter, compared to analysts' expectations of $688.74 million. During the same period last year, the firm earned $0.32 EPS. The firm's revenue was up 3.2% compared to the same quarter last year. On average, equities research analysts forecast that Envista will post 1.53 EPS for the current year.

Envista Company Profile

Envista Holdings Corporation NYSE: NVST is a global dental products and technologies company headquartered in Brea, California. The company develops, manufactures and markets products used by dentists, dental specialists, dental laboratories and other oral health professionals.

Envista's portfolio includes dental implants, orthodontic systems, digital imaging and workflow solutions, dental consumables, treatment equipment and related technologies. Its brands include Nobel Biocare, Ormco, DEXIS and Kerr, which provide products and services spanning implant dentistry, orthodontics, diagnostic imaging, restorative care and general dental practice management.

Envista was established as an independent public company in 2019 following its separation from Danaher Corporation.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.